Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy

These findings emphasize the need for intensive blood pressure management and regular UPCR monitoring during lenvatinib therapy to reduce the risk of severe proteinuria, regardless of cancer type.